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If the world heeds the warnings of
public health policy expert
Christopher Murray and the con-
structive advice ofeconomist Dean
Jamison, the health ofthe planet's
population may look very differ-
ent in 25 years than what is cur-
rently projected. Murray and
Jamison have issued a call to
action based on their novel, com- prehensive models ofthe future of
global health.
Murray, a physician at the
Harvard School of Public Health, is
coauthor of a groundbreaking report
on international health. Murray and
World Health Organization (WHO)
researcher Alan Lopez, working with
more than 100 colleagues around the
world, issued a 10-volume report, entitled
The Global Burden ofDisease this past
summer. The report, looks at data for 107
diseases, calculated for eight demographic
regions byage, sex, and cause.
At the same time,Jamison, based at the
University of California at Los Angeles,
helped draft a companion report entitled
Investing in Health Research and
Development, coauthored by Tore Godal
and James Tulloch of the WHO. This
report describes actions, especially research
funding, that could be taken to prevent the
realization ofMurray's predictions.
The Global Burden ofDisease, by all
accounts, is a sweeping, ambitious, one-
of-a-kind effort. Jamison's report builds
on that report's predictive analysis.
Together, they offer a perspective that
Murray hopes will turn traditional health
policy on its head.
Microbes orModem Stress
Murray and his team have gone beyond
the conventional world outlook on disease.
Public opinion, as well as that ofmanysci-
entists, is that the future health of the
world will be primarily characterized by a
war against lethal microbes-a struggle
against the mounting number of
deadly diseases emerging from
nature as witnessed by the world-
wide spreadofHIV, the resurgence
of tuberculosis, the specter of
Ebola, the blooming spread of
hantavirus, and the growing alarm
over drug-resistant microbes. But
Murray's group found that the
top emerging threats to world
health are heart disease-a long-
time scourge of modern society-
and severe depression, an almost
totallyunacknowledged ailment.
In painting a portrait ofhow the
health ofthe world will look in 2020,
the group found that in the develop-
ing world, where approximately 80%
ofthe global population lives, noncom-
municable diseases such as cancer, heart
disease, and mental illnesses are fast replac-
ing traditional enemies such as infectious
diseases and malnutrition as the leading
causes of disability and premature death.
By the year 2020, noncommunicable dis-
eases are expected to account 70% of all
deaths in thedeveloping regions, compared
with less than half of all deaths today. In
fact, the scientists say, adults under the age
of 70 in sub-Saharan Africa already face a
higher probability of death from a non-
communicable disease than adults of the
same age in the most developedcountries.
Death and disability due to the tradi-
tional problems of developing nations,
including communicable, maternal, and
perinatal conditions and nutritional defi-
ciencies, are estimated to dedine from 17.2
million cases in 1990 to 10.3 million in
2020, according to the group's report, due
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to progress in fighting these conditions and
education of the world's youth. This pro-
jected reduction "runs counter to the now
widely-accepted belief that infectious dis-
eases are on the ascentworldwide," Murray
said.
Among its findings, the report says that
what will be a virtual epidemic ofnoncon-
tagious disease will be brought on largely
by tobacco and alcohol abuse. By 2020,
the researchers predict, tobacco-related ill-
nesses are expected to kill more people-
8.4 million ayear-than anysingle disease,
surpassing even the HIV epidemic, with
most ofthe increase occurring in the devel-
opingworld.
By measuring disability, the report
depression would be elevated to the second
largest global health problem in the 2020s.
Depression affects 1.2% ofthe global pop-
ulation, but death rates from it are low.
Factor in disability, however, and depres-
sion counts for almost 11% ofthe burden
of disease worldwide, Murray says. "The
magnitude is tremendous," he said. "It's an
unrecognized health policy issue even
today."
Behind the shifts in disease burden is
the rapid aging of the developing world's
population. As a population's birth rate
falls, the number ofadults relative to chil-
dren increases, and the population's most
common health problems become those of
adults rather than those of children. In
China and some other parts of Asia, as
well as in Latin America, this so-called
"epidemiological transition" is much fur-
ther advanced than many public health
specialists appreciate, according to
Murray.
Perhaps most taken aback by the
report's results were the researchers them-
selves. "We were stunned. I never would
have believed this starting out, and I was
very skeptical when the first numbers,
especially on depression, were revealed,"
said Murray. "So we checked and double-
checked."
The report surprised the public health
policy community because its conclusions
are based on a new approach to measuring
health status: it used a limited number of
death certificates and extrapolation from
clinical studies and health databases to
quantify not only the number of deaths
but also the impact of premature deaths
and disability on a population. These fig-
ures were then combined into a single unit
of measurement of the overall burden of
disease called a "disability-adjusted life
year," or DALY. The study also took into
account risk factors for disease, including
tobacco, alcohol, poor water and sanita-
tion, and unsafe sex.
Road Map
The value of The Global Burden ofDisease
is that it gives governments that have
lacked even the most basic data some guid-
ance in allocating scarce monies, including
research funds and health care costs,
Murray said. "It's like a road map. You've
got to know where you are to get some-
place else."
Offering to help steer the process in
new directions is Jamison, whose report
suggests ways to coordinate the current
fractured and fractious health research
efforts toward addressing Murray's predic-
tions. Jamison's report is, however, grimly
realistic regarding the magnitude of that
challenge.
While The Global Burden ofDisease
identifies a major new research agenda for
noncommunicable diseases, there remains
the unfinished business of the problems
that have plagued the world to date, partic-
ularly infectious diseases and those that
affect maternal and child health. There is
neither the money nor the will to devote to
these problems, Jamison says. No govern-
ment, whether developed or developing,
spends more than 5% ofits total domestic
health spending on research, which the
authors say has led to "acute neglect ofthe
needs of poorer populations." In 1992,
research claimed just 3.4% of the world's
total expenditure on health, according to
Investing in Health Research and
Development. Ofa total ofalmost $56 bil-
lion invested in health research in 1992,
Jamison estimates that 95% was invested
in health problems that primarily concern
the industrialized world, and just 5% was
devoted to the health needs of developing
regions. For example, combined research
and development spending on the three
currently leading conditions in developing
nations-pneumonia, diarrheal disease,
and tuberculosis-totaled just $133 mil-
lion, or 0.2% of the world's total health
research and development spending. "Yet,
between them, these diseases make up
almost one-fifth of the global disease bur-
den," the report states. Jamison concludes
that the inability of the international
health community to allocate research and
development resources to the most debili-
tating global health problems "has deep-
ened as political will to support health
research has faltered."
Jamison's findings echo a 1990 report
by the Commission on Health Research
for Development, an independent, multi-
disciplinary international initiative formed
in 1987, which concluded that only 5% of
global research is spent to address 93% of
the years ofpotential life lost in the world.
The commission's report, entitled Health
Research: Essential Link to Equity in
Development also stated that "institutional
change" would be necessary to gather
information and facilitate efficient resource
allocation on a global basis. To this end,
Jamison's report suggested that a kind of
global consortium be established to pro-
vide a strong and reasoned voice for
research allocation, one that would help to
identify existing gaps in global health
research, particularly those that affect poor
populations. The consortium would also
help to reduce overlap and waste. This sug-
gested consortium, a "Forum for Investors
in International Health Research and
Development," would be an alliance of
governments, investors, and scientists, and
could be created under the aegis of the
WHO.
As the demand for health services by
more urbanized, educated, affluent, and
vocal populations grows, while access to
health resources for the most vulnerable
populations demands strengthening and
preservation, choices on spending will
become even harder to make. A forum
approach, suggests Jamison, could help to
identify the "best buys."
A DALYDose
Both Murray andJamison admit they have
received mixed reviews on their respective
reports from a spectrum of international
health professionals. The criticism has
focused primarily on the use ofthe DALY
scoring technique. Unlike traditional
methods for measuring the total burden of
disease, the DALY measures by counting
not just numbers ofdeaths, but by count-
ing days lost to acute disease episodes,
chronic disabilities, and premature death.
The inclusion of these factors has had a
broad impact on disease predictions for
2020. For example, in lists of disease bur-
den developed by Murray's group, some of
the current top diseases such as measles,
malaria, and iron-deficiency anemia are
replaced in predictions for 2020 by cur-
rently lower ranking conditions such as
HIV, violence, and war. Even within the
WHO, the report's sponsoring organiza-
tion, the DALY has been accused ofbeing
"flawed, with no conceptual basis," said
Jamison. However, Jamison believes this
reaction is largely politically based and that
while the DALY may not be perfect, it has
been accepted by the public health com-
munity at large as the best measurement
method available.
Others are not quite as certain of the
DALYs value as Jamison. "Some urge that
the DALY only be used-with caution
because it is not a verified, validated tool,
[but one] that creates a single measure
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based on value judgments, like the idea
that a person in their 20s is more valuable
than a child or elderly person," said John
Bryant, former director of Columbia
University's School ofPublic Health and a
faculty member of Pakistan's Aga Khan
University. "Others, including myself, see
it as a useful method that is early in its
development, but which helps assess a
global health shift that each countryshould
pay attention to."
"Even ifit is all true-and it is hard to
doubt that chronic diseases will have a
huge impact-we will face resistance in
addressing them in significant ways," says
Polly Harrison, head of the Forum on
Emerging Infectious Diseases at the
National Academy ofScience's Institute of
Medicine. "There is dwindling interest in
foreign assistance in general, as well as
what has been called 'donor fatigue' in
connection with international health over-
all. Only the needs of children have com-
manded any constituency and even that is
limited."
Murray says that he also has encoun-
tered a lot of resistance from certain dis-
ease-specific interest groups who, he says,
feel that using this type of process limits
the way they can present information. For
example, Frederick Hartman, a family
physician who has worked overseas on
United States Agency for International
Development projects and is now a board
member of Childreach-the U.S. branch
of Foster Parents Plan, a child-centered
development organization working in 40
developing countries ofAfrica, Asia, and
Latin America-views the results in
Murray's report with "healthy skepticism,"
because the report predicts that childhood
diseases oftodaywill not be as "important"
in 2020. Says Hartman, "I question what
happens to the children in the model. In
Africa, all the gains in child survival and
maternal child health have been wiped out
by HIV, and the problem is growing there
and in Asia. The report may be true if a
whole group ofyoung adults are eliminat-
ed." Hartman also said he doubts that
Americans, "who are looking at their own
issues," will support a heavy emphasis on
international health. Childreach has col-
lected only $30 million in monthly dona-
tions to help take care of1 million children
in 40 developing countries. Comparatively,
the Netherlands funds halfofthe organiza-
tion's $220 million annual budget.
Recognizing that there is widespread
reluctance to tackle international health
issues, Jamison says he is less optimistic
than he was 3 or 4 years ago about the
validity of a coordinated body to help
direct research efforts. "There is real frag-
mentation in the health community-
squabbles between physicians, who don't
want to waste money on research but [who
want to] apply available therapies now, and
researchers, who opt for better therapeutic
solutions in the future," he said.
"But I am also optimistic because I
know it can work and has in other areas,
such as the successful global effort to coor-
dinate research on agriculture and even
tropical disease," Jamison said. "We are at
a critical junction now, and we still have to
win the battle ofgetting [a] solid chunk of
support for psychiatry, cancer, heart [dis-
ease], and smoking research."
Gaining such support may be difficult,
says Nobel laureateJoshua Lederberg, pres-
ident emeritus at The Rockefeller
University and an expert in emerging
infectious diseases. Lederberg notes that
the "authority and appropriations to act
internationally have long been severelylim-
ited," and that, when prevention is part of
the formula in disease control, there "are
great psychological impediments to get
people to think about protecting their
well-being while they are still healthy, and
building this into the political and social
institutions."
Larry Friedman, director of the
Division of Epidemiology and Clinical
Application at the National Heart, Lung,
and Blood Institute, agrees that such
lifestyle changes are very difficult to
accomplish but adds that Murray's report
has "quantified a lot of things that people
have been thinking about." Said Friedman,
"The report is persuasive and probably
right, but needs more work [in] coming up
with better ways to measure the impact."
He adds, however, that these criticisms
won't stop him from using the report's
findings to help boost his budget.
John La Montagne, director of the
Division of Microbiology and Infectious
Disease at the National Institute ofAllergy
and Infectious Diseases, notes that any
increase in research funding at the NHLBI
will also be likely to help his group because
disease is now generally recognized as hav-
ing components that are infectious, genet-
ic, environmental, and behavioral. But La
Montagne says that the Murray report is
too abstract and calls it "idealistic." He also
faults the report for failing to "appreciate
that things can change"; for example, that
new viruses may arise, and for not recog-
nizing that "breakthroughs in insight can't
be planned."
Indeed, U.S. leaders have not been able
to agree on a single call to action in
addressing diseases, both emerging and
chronic. In September, news reports stated
that Vice President Al Gore had declared
that "there is no more menacing threat to
our global health today than emerging
infectious diseases." His comment was fol-
lowed by a public plea from retired army
general H. Norman Schwarzkopf, a cancer
survivor, for increased oncology research
because ofcontinuing rises in rates ofcan-
cers in the United States.
At least one major federal agency
appears to have acknowledged the conclu-
sions of the reports. The Centers for
Disease Control and Prevention has asked
Murray to conduct a 3-year analysis ofpre-
dictions for the United States. "We need to
choose where we get the biggest bang for
the buck," said James Marks, director of
the National Center for Chronic Disease
Prevention and Health Promotion.
Marks believes that eventually The
Global Burden ofDisease and Investing in
Health Research and Development will
become quite influential in helping to
drive public health policy. "If everyone
could accept something like this, it would
help rationalize decision making," said
Marks, by helping policy experts and med-
ical researchers plan for the future. Jamison
hopes health policy experts will adopt the
views of his report and use this informa-
tion to plan the way that agricultural
researchers in past decades successfully
planned and initiated global agricultural
programs. "With a division oflabor and a
sharing ofresults, it can be done," Jamison
said. "We justhave got to try."
Renee Twombly
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